Dow Down1.40% Nasdaq Down1.59%

Adamis Pharmaceuticals Corporation (ADMP)

-NasdaqCM
4.49 Down 0.19(4.06%) 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development1,740  379  208  195  
Selling General and Administrative1,011  1,335  776  762  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,751) (1,714) (984) (957)
Income from Continuing Operations
Total Other Income/Expenses Net95  307  753  3,703  
Earnings Before Interest And Taxes(2,655)(1,407)(231)2,746  
Interest Expense226  145  5,298  2,778  
Income Before Tax(2,881)(1,552)(5,529)(32)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,881)(1,552)(5,529)(32)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,881) (1,552) (5,529) (32)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,881) (1,552) (5,529) (32)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.